Render Target: SSR
Render Timestamp: 2024-11-14T23:09:16.260Z
Commit: 3c1f305a63297e594ac8d7bb5424007d592d68be
XML generation date: 2024-09-30 01:57:28.442
Product last modified at: 2024-11-05T21:00:11.574Z
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

VPS35 (E6S4I) Rabbit mAb #81453

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H M R Mk
    SENSITIVITY Endogenous
    MW (kDa) 81
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • R-Rat 
    • Mk-Monkey 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:50

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    VPS35 (E6S4I) Rabbit mAb recognizes endogenous levels of total VPS35 protein.

    Species Reactivity:

    Human, Mouse, Rat, Monkey

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Glu775 of human VPS35 protein.

    Background

    Retromer is a hetero-pentameric protein complex that mediates retrograde transport of transmembrane proteins from endosomes to the trans-Golgi network (TGN). The retromer complex consists of two protein compounds, a sorting nexin dimer and a trimeric cargo-selective complex (CSC) composed of vacuolar protein sorting-associated protein 35 (VPS35), VPS26, and VPS29 (1-3). VPS35 is the largest of the three CSC proteins, and interacts with VPS26 through its amino terminus and with VPS29 through its carboxy terminus (1).

    VPS35 and the retromer are involved in trafficking of specific cargo along the dendritic processes of neurons, including appropriate NMDA and AMPA receptor expression at synapses, and β2-adrenergic receptors (β2AR) outside of synapses and throughout the dendrite (4). It has been shown that VPS35 expression is required for survival of dopaminergic neurons through its role in mitochondrial fusion and function (5). Mutations in the VPS35 gene have been shown to cause late-onset, autosomal dominant familial Parkinson’s disease (6). VPS35 has also been implicated in Alzheimer’s disease by playing a role in regulation of Aβ peptide levels, with reduced protein levels of VPS35 seen in patient tissues (7).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    XP is a registered trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.